Recruitment Maneuvers and PEEP-guided Electrical Impedance Tomography for Abdominal Laparoscopic Surgery Patients
Launched by NGUYEN DANG THU · Feb 23, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to improve breathing during and after abdominal laparoscopic surgery, a common type of minimally invasive surgery. Researchers want to find out if using special breathing techniques, like recruitment maneuvers (which help open up the lungs) and a method called electrical impedance tomography (EIT) to personalize breathing settings, can lead to better lung function and recovery compared to standard ventilation methods. This is important because some patients may experience breathing difficulties after surgery, which can affect their recovery.
To participate in this trial, you need to be over 18 years old and scheduled for abdominal laparoscopic surgery. You should also have a higher risk of breathing problems after surgery based on a specific scoring system. However, not everyone can join; for instance, those with severe lung diseases or certain medical devices may be excluded. If you decide to participate, you'll receive personalized care to help improve your lung health during surgery, and you’ll be closely monitored to see how these techniques work for you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Scheduled for abdominal laparoscopy surgery
- • At increased (i.e., intermediate or high) risk of postoperative pulmonary complications according to the "Assess Respiratory Risk in Surgical Patients in Catalonia" (ARISCAT) score (≥ 26 points)
- • Signed written informed consent
- Exclusion Criteria:
- • Major previous lung surgery (e.g., lung resection)
- • Severe chronic obstructive pulmonary disease and/or severe emphysema
- • Increased intracranial pressure
- • Contraindications for EIT (pacemakers, automatic external defibrillators, cases of chest trauma or recent chest surgery limiting EIT belt application)
- • Presence of pneumothorax that is either undrained or newly occurred.
- • Unstable hemodynamics with a mean arterial pressure \< 60 mmHg and unresponsive to resuscitation measures, and/or heart rate \< 60 bpm.
- • Pregnancy.
- • Severe neuromuscular disease.
About Nguyen Dang Thu
Nguyen Dang Thu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through rigorous clinical studies. With a focus on innovative therapies and treatments, the organization collaborates with leading research institutions and healthcare professionals to conduct high-quality trials that adhere to the highest ethical standards. Nguyen Dang Thu leverages a robust framework of scientific expertise and operational excellence to ensure the integrity of trial processes, aiming to accelerate the development of safe and effective medical solutions for diverse health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hanoi, , Vietnam
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported